Cai-Wen Du

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Epidermal Growth Factor Receptor

Top Venues

Cancer medicine

The Journal of international medical research

Breast cancer research and treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Jia-Yi Huang, Xue-Lian Chen, Xiao-Feng Xie, Lin Song, Li-Ping Chen, Xiao-Feng Lan, Xue Bai, Xuelian Chen, Cai-Wen Du
The efficiency and safety of low-dose apatinib combined with oral vinorelbine in pretreated HER2-negative metastatic breast cancer. Cancer medicine 13 (8) (2024)
Jia-Yi Huang, Xue-Lian Chen, Xiao-Feng Xie, Lin Song, Li-Ping Chen, Xiao-Feng Lan, Xue Bai, Xuelian Chen, Cai-Wen Du
The efficiency and safety of low-dose apatinib combined with oral vinorelbine in pretreated HER2-negative metastatic breast cancer. Cancer medicine 13 (8) (2024)
Jia-Yi Huang, Xue-Lian Chen, Xiao-Feng Xie, Lin Song, Li-Ping Chen, Xiao-Feng Lan, Xue Bai, Xuelian Chen, Cai-Wen Du
The efficiency and safety of low-dose apatinib combined with oral vinorelbine in pretreated HER2-negative metastatic breast cancer. Cancer medicine 13 (8) (2024)
Xiao-Feng Xie, Qiu-Yi Zhang, Jia-Yi Huang, Li-Ping Chen, Xiao-Feng Lan, Xue Bai, Lin Song, Shui-Ling Xiong, Si-Jia Guo, Cai-Wen Du
Pyrotinib combined with trastuzumab and chemotherapy for the treatment of human epidermal growth factor receptor 2-positive metastatic breast cancer: a single-arm exploratory phase II trial. Breast cancer research and treatment (2022)
Xiao-Feng Xie, Jia-Yi Huang, Li-Ping Chen, Xiao-Feng Lan, Qiu-Yi Zhang, Lin Song, Xue- Bai, Cai-Wen Du
Acute-on-chronic liver failure following eribulin treatment for metastatic breast cancer: a case report. The Journal of international medical research 50 (7) (2022)